Justine Lopez
Tempest Technologies (United States)(US)Fate Therapeutics (United States)(US)
Publications by Year
Research Areas
Inflammatory mediators and NSAID effects, Eicosanoids and Hypertension Pharmacology, Synthesis of β-Lactam Compounds, Immune Cell Function and Interaction, T-cell and B-cell Immunology
Most-Cited Works
- → Early transcriptional and epigenetic regulation of CD8+ T cell differentiation revealed by single-cell RNA sequencing(2017)247 cited
- → TSC1 regulates the balance between effector and regulatory T cells(2013)140 cited
- → Tamoxifen augments the innate immune function of neutrophils through modulation of intracellular ceramide(2015)117 cited
- → SHARPIN controls regulatory T cells by negatively modulating the T cell antigen receptor complex(2016)57 cited
- → Proteasome activity regulates CD8+ T lymphocyte metabolism and fate specification(2017)50 cited
- → Talin Plays a Critical Role in the Maintenance of the Regulatory T Cell Pool(2017)36 cited
- → Integrin Activation Controls Regulatory T Cell–Mediated Peripheral Tolerance(2018)36 cited
- → Downregulation of 26S proteasome catalytic activity promotes epithelial-mesenchymal transition(2016)35 cited
- → Dual Blockade of EP2 and EP4 Signaling is Required for Optimal Immune Activation and Antitumor Activity Against Prostaglandin-Expressing Tumors(2023)35 cited
- → Regulation of Asymmetric Division by Atypical Protein Kinase C Influences Early Specification of CD8+ T Lymphocyte Fates(2016)8 cited